With Republicans expected to seek Congressional action, senators reportedly believe the fate of the insulin price cap will be decided on the Senate floor.
Things can get pretty crazy on the Senate floor on Saturday.
New, Important – Insulin Cap: The fate of the insulin price cap in the Adjustment Bill will be decided in real time on the Senate floor, per the multiple sources involved.
— Lisa Desjardins (@LisaDNews) August 6, 2022
Democrats have already cleared a major hurdle as lawmakers approved a provision that would lower the prices of prescription drugs.
Majority Leader Chuck Schumer said, “Democrats have received very good news. This is a big win for the American public, there was one unfortunate ruling that the scope of the inflation rebate was more limited, but the program as a whole remained intact and eventually We are one step closer to challenging Big Pharma and lowering the price of Rx drugs for millions of Americans.”
Since the adjustment can only be used for budget-related fiscal issues, Republicans are expected to raise the price cap on insulin, which would require a ruling by lawmakers.
Democrats have expressed no concern that the price cap on insulin must be lowered. One reason is that Medicare and Medicaid spend so much money on insulin each year. The US pays 8.1 times more insulin than other countries.
Usually when legislation or amendments are voted on, the outcome is agreed upon before the vote is taken, but insulin price caps are unusual and noteworthy on the Senate floor. .
Mr. Easley is Editor-in-Chief. He is also a White House press pool and a congressional correspondent for PoliticusUSA. Jason has a BA in Political Science. His graduate work focused on public policy with a specialization in the social reform movement.
Awards and Professional Membership
Member of the Association of Professional Journalists and the American Political Science Association